Compound 2433
Identifiers
- Canonical SMILES:
CC(=O)NCc1cc2nccc(-c3cc(Cl)cc4C[C@@H](Oc34)C(=O)N3CCNCC3)c2s1
- IUPAC name:
N-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)acetamide
- InChi:
InChI=1S/C23H23ClN4O3S/c1-13(29)27-12-16-11-19-22(32-16)17(2-3-26-19)18-10-15(24)8-14-9-20(31-21(14)18)23(30)28-6-4-25-5-7-28/h2-3,8,10-11,20,25H,4-7,9,12H2,1H3,(H,27,29)/t20-/m1/s1
- InChiKey:
DSUSTNYBVVVKEK-HXUWFJFHSA-N
External links
![]() 156017346 |
![]() CHEMBL4641488 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
USP7 / Ubiquitin | 7.60 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 470.12 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 2.02 | |||
TPSA | 88.14 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.0c00245 | 16 | UBP7 Q93009 |
UBB P0CG47 |
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 7.60 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4653 | PF-00356231 | DB03367 | |
0.4609 | 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine | DB06848 | |
0.4598 | 2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE | DB07605 | |
0.4353 | Aminocandin | DB05128 | |
0.4269 | Ibodutant | DB12042 | |
0.4219 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE | DB06869 | |
0.4203 | 2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE) | DB04606 | |
0.4176 | Anidulafungin | DB00362 | |
0.4158 | Proglumetacin | DB13527 | |
0.4156 | Ertiprotafib | DB06521 | |
0.4156 | Glesatinib | DB06302 | |
0.4125 | 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide | DB06969 | |
0.4116 | Sitravatinib | DB15036 | |
0.4047 | (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | DB07792 | |
0.3970 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 |